JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1997; 29:770-777
© 1997 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbagelata, A
Right arrow Articles by Wagner, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbagelata, A
Right arrow Articles by Wagner, G.

Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators

A Barbagelata, RM Califf, EB Sgarbossa, SG Goodman, AL Stebbins, CB Granger, LD Suarez, M Borruel, K Gates, S Starr, and GS Wagner

Favaloro Foundation, Buenos Aires, Argentina.

OBJECTIVES: We assessed the outcomes of patients with a first myocardial infarction with ST segment elevation, with and without the development of abnormal Q waves after thrombolysis. BACKGROUND: Prethrombolytic era studies report conflicting short-versus long-term mortality in the overall non-Q wave population, probably related to its heterogeneity. METHODS: Patients with no electrocardiographic (ECG) confounding factors or evidence of previous infarction were included. Q wave infarction was defined as a Q wave duration > or = 30 ms in lead aVF; R wave > or = 40 ms in lead V1; any Q wave or R wave < or = 10 ms and < or = 0.1 mV in lead V2; or Q wave > or = 40 ms in at least two of the following leads: I, aVL, V4, V5 or V6. In-hospital clinical events and mortality at 30 days and 1 year were assessed. RESULTS: No Q waves developed in 4,601 (21.3%) of the 21,570 patients. This group comprised more women and had a lower Killip class, lower weight and less anterior baseline ST elevation. The non-Q wave group had less in-hospital cardiogenic shock (2.1% vs. 3.3%, p < 0.0001), less heart failure (8.5% vs. 13.9%, p < 0.0001) and a trend toward less stroke (0.7% vs. 1.0%, p = 0.07) but an increased use of angioplasty (28% vs. 24%, p = 0.0001). The unadjusted mortality rate in the non-Q wave group was lower at 30 days (0.9% vs. 1.8%, p = 0.0001) and 1 year (2.7% vs. 4.2%, p = 0.0001), as was the adjusted 30-day mortality rate (4.8% vs. 5.3%, p < 0.0001). CONCLUSIONS: Patients with no ECG confounding factors or evidence of previous infarction who do not develop Q waves after thrombolysis have a better 30-day and 1-year prognosis than patients with a Q wave infarction.


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
H. Tomoda and N. Aoki
Pathophysiology of Early Coronary Angioplasty with Stenting on Non-Q-Wave vs Q-Wave Myocardial Infarction
Angiology, October 1, 2001; 52(10): 671 - 679.
[Abstract] [PDF]


Home page
Eur Heart JHome page
J Abdulla, B Brendorp, C Torp-Pedersen, L Kober, and on behalf of the TRACE study group
Does the electrocardiographic presence of Q waves influence the survival of patients with acute myocardial infarction?
Eur. Heart J., June 2, 2001; 22(12): 1008 - 1014.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
M. I. Furman, H. L. Dauerman, R. J. Goldberg, J. Yarzbeski, D. Lessard, and J. M. Gore
Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial q-wave and non-q-wave myocardial infarction: a multi-hospital, community-wide perspective
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1571 - 1580.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Kennon, K Barakat, A Suliman, P K MacCallum, K Ranjadayalan, P Wilkinson, and A D Timmis
Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction
Heart, July 1, 2000; 84(1): 41 - 45.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Al-Mohammad, M Y Norton, I R Mahy, J C Patel, A E Welch, P Mikecz, and S Walton
Can the surface electrocardiogram be used to predict myocardial viability?
Heart, December 1, 1999; 82(6): 663 - 667.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
P. Porela, H. Helenius, K. Pulkki, and L.-M. Voipio-Pulkki
Epidemiological classification of acute myocardial infarction: time for a change?
Eur. Heart J., October 2, 1999; 20(20): 1459 - 1464.
[Abstract] [PDF]


Home page
CirculationHome page
S. G. Goodman, A. Langer, A. M. Ross, N. M. Wildermann, A. Barbagelata, E. B. Sgarbossa, G. S. Wagner, C. B. Granger, R. M. Califf, E. J. Topol, et al.
Non–Q-Wave Versus Q-Wave Myocardial Infarction After Thrombolytic Therapy : Angiographic and Prognostic Insights From the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries–I Angiographic Substudy
Circulation, February 10, 1998; 97(5): 444 - 450.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1997 by the American College of Cardiology Foundation.